| INTRODUC TI ON
The 46,XY disorder of sex development (DSD) due to gonadal dysgenesis is a congenital disorder caused by alterations in the complex process of gonadal determination. 1 There is a wide phenotype spectrum ranging from a partial form, characterised by variable degrees of external genitalia undervirilisation, development of Mullerian derivatives and testosterone production, to a complete form with female external and internal genitalia.
There are scarce data on long-term follow-up of 46,XY partial gonadal dysgenesis (PGD) patients, regarding spontaneous puberty, 2 risk of a gonadal tumour development 3 and gender adjustment, making it difficult to provide comprehensive information to parents.
Our aim was to describe the phenotype, genotype and long-term outcomes of a large cohort of patients with 46,XY PGD followed until adulthood.
| SUBJEC TS AND ME THODS
Thirty-three patients with 46,XY PGD were included in this retrospective longitudinal study conducted at Hospital das Clínicas of São Paulo (HCFMUSP). Twenty-six patients were initially evaluated at our service, and 7 had already had a previous genitoplasty and/ or gonadectomy elsewhere. Written informed consent was obtained from all the patients. The clinical and molecular data from 8 patients were previously reported.
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Inclusion criteria were as follows: ≥17 years of age at last evaluation, a 46,XY karyotype in a G-banded karyotyping analysis of at least 30 peripheral blood lymphocytes, atypical genitalia associated with the presence of Mullerian derivatives and/or at least one gonad with histopathological features compatible with testicular dysgenesis. Data regarding sex assignment, age at first and last evaluation, external genitalia appearance, the hormonal profile throughout the follow-up and at last visit, pubertal development and gonadal tumour incidence were collected from medical records. Patients were assumed to be at prepubertal age if they were younger than 9 years, at pubertal age if they were 9.1-16 years old, and at adult age if they were older than 17 years. Micropenis is defined as a normally structured penis which in its fully stretched length is 2.5 standard deviations (SDs) below the mean for age 8 and microphallus is defined as a micropenis associated with hypospadias.
The external masculinisation score (EMS) was calculated as previously described. 9 To determine the hormonal profile, luteinising hormone (LH), follicle-stimulating hormone (FSH) and testosterone were measured by immunoradiometric or immunofluorimetric assays at the first and at each semi-annual follow-up visit. Spontaneous puberty was assumed if virilisation was observed in pubertal patients or was reported by the patients that came in adulthood in conjunction with the presence of pubertal signs (the presence of secondary sex characteristics, such as increased penile length and testis diameter > 2.5 cm, when they were palpable) and with male serum testosterone levels without the use of exogenous testosterone.
For prepubertal patients, a human chorionic gonadotropin (hCG) test was performed by means of 4 intramuscular injections at 50-100 IU/kg each, with a 4-day interval between the injections. A single dose of 5000 IU of hCG was administered to adult patients.
Serum levels of testosterone were measured before and 72 hours after the last hCG injection.
Data on a gonadal histology were collected from medical records.
Physical evaluation of the palpable scrotal testes of male patients was performed at every medical visit (each semester or annually), and testicular ultrasonography was performed once every 2 years.
If a suspicious nodule was identified, tumour markers (β-HCG, α-fetoprotein and carcinoma embryonic antigen) were tested, and a gonadectomy was indicated if needed.
Continuous variables were described as median and range.
Differences in the categorical variables among the groups were analysed by the Chi-square test or Fisher's exact test, when appropriate.
The Mann-Whitney U test served as a nonparametric test, and data with P < .05 were considered statistically significant. All analyses were performed in SPSS Statistics 24.0 software (Chicago, IL).
Evaluation of psychosexual characteristics was performed on 21
patients by a psychologist specializing in DSDs. Self-reported gender identity, the self-reported gender role in childhood, the desire to change gender and satisfaction with gender and with their sexual life were analysed via a questionnaire (see Appendix 1). 
| RE SULTS
The patients' age at first visit ranged from 10 days to 43 years (median 13 years), and at last visit, from 17 to 53 years (median 26.5 years).
Follow-up ranged from 3 to 26 years (median 13.2 years). Nineteen patients had Mullerian derivatives (57%). Histological analysis identified testicular dysgenesis in 18 patients (67%) and the absence of gonadal tissue in 9 (33%).
| Sex assignment and the EMS
Thirteen patients were assigned female and 20 were assigned male at birth. Twenty-six patients were assigned before the year 1990
(16 patients to male and 10 patients to female), and seven patients were assigned between 1990 and 1999 (4 patients to male and 3 patients to female). The median EMS at first evaluation in patients without a previous genitoplasty was 3.5 (1.0-5.5) for the patients assigned female and 6.0 (3.0-7.5) for the patients assigned male at birth (P = .002). This difference in the EMS between the two sexes was observed in the patients assigned before and after the year
1990.
Four patients changed their gender in adulthood, two from male to female and two from female to male. These four patients visited our hospital at an adult age.
The patients were grouped on the basis of their gender and not on their sex assignment.
| Female gender group (n = 13)
Two patients came at prepubertal age (patients 1 and 2), four at pubertal (patients 3-6) and seven after pubertal age (patients 7-13). Three patients had already had a gonadectomy and genitoplasty (patients 6, 7 and 9). Amongst the 10 patients without previous genital surgery, external genitalia ranged from normal female (patient 12), female with clitoromegaly (patients 1-5, 8
and 11) to micropenis (patient 11). Six patients had two perineal openings (patients 1, 3, 4, 5, 6 and 13), and five patients had a single perineal opening (patients 2, 8, 10, 11 and 12). All the patients had bilateral cryptorchidism. These patients had elevated serum gonadotropin levels with predominance of FSH levels (range from 38 to 77 IU/L) over LH levels (range from 5 to 32 IU/L) Table 1 .
All female patients had undergone feminizing genitoplasty and bilateral gonadectomy. Oestrogen replacement was started at a median age of 14 (10-31 years) with normal breast development.
| Male gender group (n = 20)
Twelve patients were evaluated at prepubertal age (patients 14-18, There was no statistically significant difference in phallus size
SDs between the patients with preserved testosterone secretion and those who received testosterone replacement and also at their first and last evaluation.
| Testosterone production in patients with 46,XY PGD
At first evaluation, 28 patients who did not undergo bilateral gonadectomy in childhood were evaluated regarding testosterone production ( Figure 1 ). Fourteen of them were at prepubertal age At last evaluation, five male patients maintained normal male adult testosterone levels (median 16.7 nmol/L). Four patients had high LH (median 11 IU/L) and FSH levels (median 24 IU/L), and one subject had normal gonadotropin levels (patient 25) at 17 years of age Table 4 .
Altogether, twelve patients (57%) had gone through spontaneous puberty. At last evaluation, five of eight patients with male social sex who had gone through spontaneous puberty still had normal testosterone production.
| Psychosexual follow-up according to gender
Ten patients assigned female and 11 patients assigned male at birth were evaluated. Gender dysphoria and gender change were observed in four patients, two from each gender group. None of the patients reported nonbinary or gender-fluid feelings. Patients 21 and 33 had atypical genitalia and were first assigned female at birth. They had manifested male behaviour since childhood, preferring boys' hobbies and clothes.
Patient 21 had a feminizing genitoplasty and gonadectomy at 1.6 years of age elsewhere and had no psychological evaluation and follow-up. At age 19, he changed his gender to male, and testosterone replacement was started. At 27 years of age, he came to our institution looking for neophallus surgery.
Patient 33 never had medical assistance. He had had male gender identity since he was 9 years old. Virilisation due to spontaneous puberty was noticed when he was 15 years of age. At the time, he changed his gender to male. He was first seen at our service at age 26, when masculinizing genitoplasty was performed.
At final evaluation, all the 21 patients had gender identity concordant with their self-reported gender role in childhood and were satisfied with their gender. Four females (40%) and eight males (73%) had a steady partner. Penetrative sexual intercourse was reported by eight females (80%) and by nine males (81%), among whom six females (75%) and eight males (81%) reported satisfaction with sexual life and orgasm.
None of the patients from both genders have offspring or adopted children.
| Testosterone production and gender
There was no relation between postnatal testosterone levels and gender considering the highest serum testosterone level at baseline condition or after the hCG stimulation test observed at the followup (P = .9).
| Incidence of gonadal tumours
During follow-up, patients underwent bilateral gonadectomy due to female gender, for impaired testosterone secretion, for an atrophic cryptorchid testis, or because of a gonadal tumour.
Thirteen patients had bilateral or unilateral gonadectomy at prepubertal age at a median age of 4 years (1.2-8.8), and no evidence of germ cell neoplasia was found. Fifteen patients had a gonadectomy at pubertal age or in adulthood at a median age of 21 (9.9-47.9), and a testicular tumour was found in two subjects (patients 31 and 32). 
| Molecular diagnosis
Pathogenic or likely pathogenic variants were found in nine sporadic cases and in two familial cases, eight identified by Sanger sequencing and three by targeted massively parallel sequencing (Table 5 ). All the identified variants are heterozygous and located in genes previously associated with gonadal dysgenesis phenotypes (NR5A1, SRY, WT1, MAP3K1 and FGFR2). Nine variants had already been described, [4] [5] [6] [7] 25 and two variants are novel (in MAP3K1 and FGFR2, the familial cases).
None of the variants was found in population databases, including the Brazilian ABraOM. 23 NR5A1 defects were the most common, being responsible for 18% of the cases, and in silico and in vivo studies corroborated the deleteriousness of NR5A1 variants, as previously reported by our group. 4, 7 None of these patients had adrenal failure. Segregation analysis by Sanger sequencing was possible in eight of ten families and confirmed segregation with the phenotype in five families and de novo status of the two WT1 variants.
| D ISCUSS I ON
The Sex assignment is the most controversial issue of DSD management. In our cohort, most patients were assigned before the 1990s, and male sex assignment was significantly more frequent in patients with a higher EMS, in a ratio of 1.5 males to 1.0 female. The International
Disorder of Sex Development (I-DSD) Registry reported an increase in the male-to-female sex assignment ratio in 46,XY dysgenetic DSD babies with time, starting from a ratio of 0.4 before the 1990s to a ratio of 1.5 in children born after 1999, regardless of the EMS.
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Despite this increasing trend on male sex assignment, there are scarce data on pubertal development of those patients. In our cohort, spontaneous puberty was observed in 57% of the patients who did not undergo bilateral gonadectomy in childhood. In adulthood, all the male patients maintained testosterone secretion, except for the oldest, who showed a decrease in testosterone secretion at the age of 34. They all had high LH levels (>10 IU/L), with the exception of the youngest, indicating partial Leydig cell dysfunction. Regarding reproductive function, high FSH levels (>20 IU/L) were found in most patients manifesting compromised spermatogenesis although the sperm count was not performed.
In one retrospective study on pubertal development of 46,XY PGD patients, 9 of 10 patients had gone through spontaneous puberty with high FSH levels and progressive elevation of LH.
2 These F I G U R E 1 Flow chart of patients' follow-up regarding testosterone secretion and gonadal tumour incidence patients had a mild-gonadal-dysgenesis phenotype as 60% had a penile urethra opening and all of them were assigned male at birth.
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In humans, the process of gonadal determination is quite complex 1 and a molecular defect was identified in 20% and 40% of the 46,XY gonadal dysgenesis patients who were studied by Sanger
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and target massively parallel sequencing, respectively. 28 NR5A1
and MAP3K1 allelic variants were the most frequent molecular diagnosis.
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In our study, likely pathogenic or pathogenic allelic variants were identified in 33% of the patients, in one of the following genes:
NR5A1, SRY, WT1, MAP3K1 and FGFR2. NR5A1 defects (n = 6) were the most frequent in the whole cohort and also among the 12 patients who developed spontaneous puberty (n = 4). Moreover, three of these patients were assigned female at birth owing to their severely undervirilised genitalia. This finding is in agreement with other reports. [29] [30] [31] [32] [33] [34] [35] In those cases, the severe undervirilisation of external genitalia could not predict virilisation in adulthood because testosterone secretion recovered during puberty for unknown reasons.
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SRY defects have been mostly associated with complete gonadal dysgenesis and rarely with partial gonadal dysgenesis. 25, [37] [38] [39] The SRY p.Arg30Ile pathogenic allelic variant was identified in one of our patients with spontaneous puberty. This same variant was also found in another Brazilian family, including affected members with various phenotypes, ranging from complete to partial gonadal dysgenesis. 25 In vitro studies proved the deleteriousness of the variant. 25 None of the reported patients with PGD due to SRY variants had preserved testosterone secretion. 25, [37] [38] [39] Missense defects in Wilms' tumour suppressor gene 1 (WT1) The mechanism by which the gonadal FGF signal is transduced intracellularly remains unclear, but FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK signalling pathway, and these patients may have a digenic inheritance cause of gonadal dysgenesis.
The prevalence of germ cell tumours in PGD is variable.
Reported rates range between 16% and 30% 3 and for Denys-Drash and Frasier syndromes is as high as 40%-60%. 50 In our cohort, two patients (7%) had a germ cell tumour: one had an invasive seminoma, and the other had bilateral gonadoblastoma associated with in situ germ cell neoplasia. Both patients had additional factors for germ cell tumour development: one had an abdominal gonad, and the other had both testicles lying within the scrotum but carried a WT1 mutation. Pre-and postnatal androgen exposure seems to contribute to male gender identity in patients with the 46,XY DSD due to 5alpha-reductase type 2 and 17beta-hydroxysteroid dehydrogenase type 3 deficiencies. In those patients, despite the severe undervirilisation and female rearing, a high rate of gender change to male is observed, ranging from 50% to 63% and from 39% to 64%, respectively. 51 In 46,XY PGD, testosterone production is quite variable during foetal and adult life. In our cohort, postnatal testosterone levels were not related to the gender. In addition, among the 5 patients assigned female at birth who virilised at puberty, 3 harboured NR5A1 variants, and gender change to male was observed in one patient, who reported gender dysphoria since childhood.
Gender dysphoria had rarely been observed in patients with PGD. To our knowledge, only one case of female-to-male gender change has been reported. 34 This patient harboured a NR5A1 variant, was assigned female at birth, presented with virilisation at puberty and changed his gender at 18 years of age.
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Nonetheless, no gender change was observed among another six PGD patients with NR5A1 defects already described, who had gone through spontaneous virilisation. [29] [30] [31] 33, 35, 36 Together with the already published cases of NR5A1 defects, among the 10 patients assigned female at birth with virilisation at puberty, two patients changed their gender to male. This data does not suggests that testosterone production at puberty is a determinant of gender change, but it should play a role in 46,XY PGD patients' gender, although the small sample size does not allow us to make any conclusion.
The psychosexual evaluation in adulthood revealed that the patients were satisfied with their final social sex, and ~80% of the patients reported satisfaction with their sexual life.
| CON CLUS ION
The present study represents the largest 46,XY PGD cohort showing clinical outcomes and molecular analysis. Spontaneous puberty was observed in 57% of the patients with 46,XY PGD, being NR5A1 defects the most prevalent among all patients and among those with spontaneous puberty. A germ cell tumour was detected only after puberty in 7% of the patients. Gender change due to gender dysphoria was reported by 12% of the patients. All the patients reported satisfaction with their gender and most of them with their sexual life.
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